TARS
Tarsus Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$90.78
+9.10%Leverage
- Debt / equity
- 0.26x
- Net debt / equity
- -0.33x
- Debt / assets
- 0.15x
- Debt / EBITDA
- -2.52x
- Net debt / EBITDA
- 3.29x
Liquidity & coverage
- Current ratio
- 3.20x
- Quick ratio
- 3.17x
- Cash ratio
- 2.56x
- Interest coverage
- -5.63x
- EBITDA / interest
- -4.09x
- Working capital
- $386.2M
Cash & dividend
- FCF / debt
- 0.69x
- Cash flow / debt
- 0.90x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026